3D InSight™ | 3D In Vitro Liver Disease
Industry-ready 3D In Vitro Liver Disease Solutions
Benefit from our market-leading 3D in vitro human models for liver disease drug discovery. Our controlled, scalable, biologically relevant, and cost-effective screening platform for MASH and MASLD unlocks the full potential of your research.
The 3D InSight™ Human Liver Microtissues facilitate studies of disease mechanisms, enable early assessment of drug safety and efficacy, and accurately simulate human liver pathology. InSphero's 3D in vitro liver disease platform:
- Enhances your ability to predict human responses
- Reduces the chances of late-stage clinical failures
- Expedites the drug discovery process
- Preserves valuable resources for your team
Why 3D In Vitro Liver Disease with InSphero?
InSphero’s 3D In Vitro Liver Disease Platform reflects the needs of liver drug discovery researchers: high physiological relevance, uniformity, scalability, which bring your MASH and MASLD research to the next level.
Based on the 3D in vitro human liver gold standard
Unique pairs of diseased and healthy 3D microtissues
Scalable & automation-friendly 3D in vitro liver disease platform
3D In Vitro MASH Screening for Lead Selection
Starting in April 2026
Benefit our scalable, reliable, and reproducible 3D Liver MASH Model for:
- Cost-effective identification and prioritization of promising MASH candidates
- De-risked go / no-go decisions through multiparametric analysis of key MASH hallmarks
Services & Products
Click to discover
Our Approach to 3D In Vitro Liver Disease
In-depth requirement analysis
Our expert team has supported hundreds of research groups in 3D cell culture. We invest efforts to understand your goals and requirements, so we can deliver fast and high-quality results.
Project proposal
Whether you use our products in-house or partner with us to utilize our 3D in vitro liver disease services, you receive a comprehensive proposal to outline the research project.